Full Schedule

7:00 AM – 8:00 AM CEST

Coffee with Exhibitors

Location: Hall C

7:00 AM – 8:00 AM CEST

Poster Session A Set-Up

Location: Hall C

7:00 AM – 6:00 PM CEST

Lactation Room

Location: Meeting Room 28

7:00 AM – 6:00 PM CEST

Registration

Location: Hall F6-F7 Lobby

7:00 AM – 6:00 PM CEST

Speaker Ready Room

Location: Meeting Room 21

8:00 AM – 8:30 AM CEST

Welcome to ICPE 2022

Location: Congress Hall D4

Speaker: – University of Southern Denmark

Speaker: – UPenn Center for Pharmacoepidemiology Research & Training

8:30 AM – 10:00 AM CEST

Strategies for Successful Mass Vaccination Rollout: Balancing Science, Politics, Communication and Trust [Keynote Plenary]

Location: Congress Hall D4

Keynote Speaker: – Danish Health Authority

8:00 AM – 6:00 PM CEST

Exhibits/Poster Session A

Location: Hall C

10:00 AM – 10:30 AM CEST

Break/Exhibits/Posters

Location: Hall C

10:30 AM – 12:00 PM CEST

Using Real-World Data and Pharmacoepidemiologic Methods to Advance the Science of Deprescribing Research

Location: C1M5

Presenting Author:

Author: – University of Kentucky College of Pharmacy

Author: – UNC School of Medicine, Division of Geriatrics

Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Author: – Inserm

Author: – University of Sydney

Author: – Harvard Medical School Department of Population Medicine

Author: – Brown University School of Public Health

Geriatric Pharmacoepidemiology

10:30 AM – 12:00 PM CEST

Post-authorization Regulatory Strategies to Evaluate Drug Safety in Pregnancy: How to Optimize the Design of Registries & Database Studies

Location: Congress Hall D5

Presenting Author: – Harvard School of Public Health

Author: – US Food and Drug Administration

Author: – University of California, San Diego

Author: – RTI Health Solutions

Author: – Harvard Medical School

Author: – EMA

Pregnancy and Lactation

10:30 AM – 12:00 PM CEST

Representing and Leveraging Heterogeneity Between Data Sources in Multi-database Pharmacoepidemiologic Studies

Location: C1M0

Presenting Author: – Agenzia Reg Della Sanit

Author: – University of Utrecht

Author: – Gillian Hall Epidemiology Ltd

Author: – McGill Dept of Epidemiology, Biostatistics and Occupational Health

Author: – Rutgers Robert Wood Johnson Medical School

Author: – RTI Health Solutions

Author: – UMC Utrecht

Methods in Pharmacoepidemiology

10:30 AM – 12:00 PM CEST

Data Harmonization, Standardization, and Quality Assessment in Distributed Health Data Networks: Lessons from Around the World

Location: Congress Hall D2

Presenting Author: – TriNetX

Author: – The University of Manitoba

Author: – Harvard Pilgrim Health Care Institute

Author: – TriNetX

Author: – GSK

Author: – European Medicines Agency

Informatics

10:30 AM – 12:00 PM CEST

Methodological Challenges in Assessing the Impact of Digital Technologies on Patient Adherence

Location: C1M1

Presenting Author: – University of Uppsala

Author: – Grigore T. Popa University of Medicine and Pharmacy, Romania

Author: – University Medical Center Groningen

Author: – University of Antwerp, Belgium

Author: – Altınbaş University Faculty of Pharmacy, Istanbul, Turkey

Author: – Luxembourg Institute of Health, Luxembourg

Author: – University of Aveiro

Author: – CIRFF, Center of Pharmacoeconomics and Drug utilization Research, Department of Pharmacy, University of Naples Federico II, Naples, Italy

Author: – Andalusian Health Service/University of Malaga, Spain

Author: – Faculty of Pharmacy, Medical University of Sofia, Bulgaria

Author: – University of Novi Sad, Serbia

Author: – University of Malaga, Spain

Drug Utilization Research

12:00 PM – 1:30 PM CEST

Committee Meetings

12:00 PM – 1:30 PM CEST

Lunch/Exhibits/Posters

Location: Hall C

12:15 PM – 1:15 PM CEST

Spotlight Poster Session A

Location: Hall E-South

1:30 PM – 3:00 PM CEST

A Tivoli Gardens Distillery of Applied Methods

Location: C1M5

Moderator: – Johnson & Johnson

Moderator: – Leibniz Institute for Prevention Research and Epidemiology - BIPS

Methods in Pharmacoepidemiology

1:30 PM – 1:45 PM CEST

Inverse Probability Weighting or Multiple Imputation for Nonmonotone Missing Data?

Location: C1M5

Presenting Author: – UNC Gillings School of Global Public Health

Co-Author: – UNC Chapel Hill Gillings School of Global Public Health

Co-Author: – University of North Carolina

Co-Author: – University of North Carolina at Chapel Hill

Methods in Pharmacoepidemiology

1:45 PM – 2:00 PM CEST

Sampling Biases in Analyses of Prescription Durations

Location: C1M5

Presenting Author: – Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark (SDU)

Co-Author: – University of Southern Denmark

Methods in Pharmacoepidemiology

2:00 PM – 2:15 PM CEST

The impact of parametric assumptions on the bias-variance tradeoff for causal analysis of time-to-event outcomes

Location: C1M5

Presenting Author: – Target RWE

Co-Author: – UNC Eshelman School of Pharmacy

Co-Author: – Target RWE

Methods in Pharmacoepidemiology

2:15 PM – 2:30 PM CEST

Successful Implementation of Inverse-probability-of-screening Weights to Address Differential Outcome Screening: Effects of Statin Persistence on Breast Cancer Risk in Denmark

Location: C1M5

Presenting Author: – RTI Health Solutions

Co-Author: – University of Southern Denmark

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – School of Medicine, University of North Carolina at Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Methods in Pharmacoepidemiology

2:30 PM – 2:45 PM CEST

Analytic Methods for Elucidating Continuous Dose-response Associations in the Presence of Spike-effects: Avoiding the Illusion of a Safe Dose

Location: C1M5

Presenting Author: – Vanderbilt University Medical Center

Co-Author: – Vanderbilt University Medical Center

Methods in Pharmacoepidemiology

2:45 PM – 3:00 PM CEST

Antidepressant Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Pharmacoepidemiologic Screening to Detect Three-Way Drug Interaction Signals

Location: C1M5

Presenting Author: – University of Pennsylvania

Co-Author: – Perelman School of Medicine at the University of Pennsylvania

Co-Author: – Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, The University of Pennsylvania

Co-Author: – University of Pennsylvania

Co-Author: – Perelman School of Medicine at the University of Pennsylvania

Methods in Pharmacoepidemiology

1:30 PM – 3:00 PM CEST

Antidiabetics - Not Just About Diabetes

Location: Congress Hall D2

Moderator: – Utrecht University

Moderator: – Takeda Pharmaceuticals International

Drug Effectiveness

1:30 PM – 1:45 PM CEST

Incretin-based Drugs and the Prevention of Chronic Obstructive Pulmonary Disease Exacerbations Among Patients with Type 2 Diabetes

Location: Congress Hall D2

Presenting Author: – McGill Dept of Epidemiology, Biostatistics and Occupational Health

Co-Author: – McGill Dept of Epidemiology, Biostatistics and Occupational Health

Co-Author: – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada

Co-Author: – McGill University

Co-Author: – McGill University, Montreal, Quebec, Canada

Drug Effectiveness

1:45 PM – 2:00 PM CEST

Association Between Sodium Glucose Co-transporter 2 Inhibitors and Incident Glaucoma in Patients with Type 2 Diabetes: A Multi-institutional Cohort Study in Taiwan

Location: Congress Hall D2

Presenting Author: – Keelung Chang Gung Memorial Hospital

Co-Author: – National Cheng Kung University

Drug Effectiveness

2:00 PM – 2:15 PM CEST

Heterogeneous Treatment Effect of Glucagon-like Peptide 1 Receptor Agonists on Asthma/COPD exacerbation: Machine-learning Analysis of Two Nationwide Cohorts

Location: Congress Hall D2

Presenting Author:

Co-Author: – Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina at Chapel Hill

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Drug Effectiveness

2:15 PM – 2:30 PM CEST

Risk of Hepatic Events Associated with Sodium-glucose cotransporter-2 Inhibitors in Patients with Type 2 Diabetes: A Nationwide Cohort Study

Location: Congress Hall D2

Presenting Author: – School of Pharmacy, Sungkyunkwan University

Co-Author: – School of Pharmacy, Sungkyunkwan University

Co-Author: – School of Pharmacy, SKKU

Co-Author: – Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea

Co-Author: – Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Co-Author: – McGill University

Co-Author: – School of Pharmacy, Sungkyunkwan University

Drug Effectiveness

2:30 PM – 2:45 PM CEST

Incretin-based Drugs and the Incidence of Prostate Cancer Among Patients with Type 2 Diabetes

Location: Congress Hall D2

Presenting Author: – McGill Dept of Epidemiology, Biostatistics and Occupational Health

Co-Author: – The Lady Davis Research Institute, Centre for Clinical Epidemiology, Jewish General Hospital, QC, Canada

Co-Author: – McGill University

Co-Author: – McGill University, Montreal, Quebec, Canada

Drug Effectiveness

2:45 PM – 3:00 PM CEST

Association of Glucagon-like peptide-1 Receptor Agonists with Serious Liver Events: Scandinavian Cohort Study

Location: Congress Hall D2

Presenting Author: – Karolinska Institutet

Co-Author: – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm

Co-Author: – Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Co-Author: – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden

Co-Author: – Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

Co-Author: – HUNT Research Center, Faculty of Medicine, NTNU—Norwegian University of Science and Technology, Levanger, Norway

Co-Author: – Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark

Co-Author: – Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet

Co-Author: – Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden

Drug Effectiveness

1:30 PM – 3:00 PM CEST

From Motherhood to Childhood, Moody to Healthy

Location: Congress Hall D5

Moderator: – Pfizer Inc

Moderator: – RTI Health Solutions

Pregnancy and Lactation

1:30 PM – 1:45 PM CEST

Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and the Risk of Preterm Birth

Location: Congress Hall D5

Presenting Author: – KI Research Institute

Co-Author: – University of California, San Francisco

Co-Author: – KI Research Institiute

Co-Author: – KI Research Institute

Co-Author: – University of California, San Francisco

Co-Author: – KI Research Institute

Co-Author: – Sheba Medical Center

Co-Author: – University of California, San Francisco

Pregnancy and Lactation

1:45 PM – 2:00 PM CEST

Lisdexamfetamine in Early Pregnancy and Risk of Major Congenital Malformations

Location: Congress Hall D5

Presenting Author: – Norwegian Institute of Public Health

Co-Author: – Karolinska Institutet

Co-Author: – Norwegian Institute of Public Health

Co-Author: – Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden

Co-Author: – Department of Chronic Diseases, Norwegian Institute of Public Health, Norway

Pregnancy and Lactation

2:00 PM – 2:15 PM CEST

Psychostimulant Use During Pregnancy and the Risk of Neurodevelopmental Disorders in Children

Location: Congress Hall D5

Presenting Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Harvard School of Public Health

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Co-Author: – Harvard Medical School

Pregnancy and Lactation

2:15 PM – 2:30 PM CEST

Antidepressant Treatment in Pregnancy and Maternal Mental Health in the Postpartum Year: A Danish Registry Linkage Study in Pregnant Women with Obsessive‐compulsive Disorder

Location: Congress Hall D5

Presenting Author: – University of Oslo

Co-Author: – National Centre for Register-based Research - Aarhus University

Co-Author: – University of Oslo

Pregnancy and Lactation

2:30 PM – 2:45 PM CEST

Topiramate During Pregnancy and the Risk of Neurodevelopmental Disorders in Children

Location: Congress Hall D5

Presenting Author: – Harvard School of Public Health

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Co-Author: – University of Pittsburgh School of Medicine

Co-Author: – Harvard Medical School

Pregnancy and Lactation

2:45 PM – 3:00 PM CEST

Association of Prenatal Antidepressant Exposure with Trajectories and Acceleration of Body Mass Index in Children from 6 Week to 8 Years of Age

Location: Congress Hall D5

Presenting Author: – University of Oslo

Co-Author: – Department of Pharmacy, University of Oslo

Co-Author: – University of Oslo

Pregnancy and Lactation

1:30 PM – 3:00 PM CEST

Challenges in Healthy Aging

Location: C1M0

Moderator: – NCKU Institute of Clinical Pharmacy and Pharmaceutical Sciences

Moderator: – USC College of Pharmacy

Geriatric Pharmacoepidemiology

1:30 PM – 1:45 PM CEST

Serious Hypoglycemia and the Risk of Dementia: A Population-based Cohort Study Using Exposure Density Sampling

Location: C1M0

Presenting Author: – University of Waterloo

Co-Author: – School of Pharmacy, University of Waterloo

Co-Author: – Departments of Internal Medicine and Community Health Science, Max Rady College of Medicine, University of Manitoba

Co-Author: – School of Public Health Sciences, University of Waterloo

Co-Author: – Women's College Hospital, Toronto, Ontario, Canada

Co-Author: – School of Pharmacy, University of Waterloo

Geriatric Pharmacoepidemiology

1:45 PM – 2:00 PM CEST

Evaluation of Fall-related Injuries Following a Potential Calcium Channel Blocker — Loop Diuretic Prescribing Cascade

Location: C1M0

Presenting Author: – University of Florida College of Pharmacy

Co-Author: – University of Florida Department of Pharmaceutical Outcomes and Policy

Co-Author: – University of Florida - Department of Pharmaceutical Outcomes & Policy

Co-Author: – VA North Florida/South Georgia Health Care System

Co-Author: – University of Florida

Co-Author: – University of Florida College of Medicine

Co-Author: – University of Utah College of Pharmacy

Co-Author: – University of Florida

Geriatric Pharmacoepidemiology

2:00 PM – 2:15 PM CEST

Translation of a Medicare Claims-based Frailty Index from International Classification of Diseases 9th Revision to 10th Revision

Location: C1M0

Presenting Author: – UNC Gillings School of Global Public Health

Co-Author:

Co-Author: – Department of Physical Medicine and Rehabilitation, School of Medicine, UNC Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Co-Author: – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Geriatric Pharmacoepidemiology

2:15 PM – 2:30 PM CEST

Tobacco Smoking, Intensity, and Duration Are Associated with Frailty Among People with HIV

Location: C1M0

Presenting Author: – University of Washington

Co-Author: – University of Washington

Co-Author: – Stanford University

Co-Author: – University of Washington

Co-Author: – University of Alabama-Birmingham

Co-Author: – University of Washington

Co-Author: – The University of Manitoba

Co-Author: – Harvard University

Co-Author: – University of North Carolina-Chapel Hill

Co-Author: – University of California-San Francisco

Co-Author: – University of California-San Diego

Co-Author: – University of Alabama-Birmingham

Co-Author: – University of Rochester

Co-Author: – University of Washington

Co-Author: – College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba

Disease Epidemiology/Clinical Course

2:30 PM – 2:45 PM CEST

Impact of Different Poststroke Antihypertensive Regimens on Cardiovascular Outcomes and Mortality in People with Dementia: Four Continents for Dementia (4C4D) Study

Location: C1M0

Presenting Author: – Monash University

Co-Author: – University of Hong Kong

Co-Author: – School of Nursing, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom

Co-Author: – Monash University

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – University College London

Co-Author: – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

Co-Author: – Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong

Co-Author: – Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia

Geriatric Pharmacoepidemiology

2:45 PM – 3:00 PM CEST

Frailty-gradient Risk of Mortality Comparing Primary Endocrine Therapy and Surgery in Treating Women with Early Breast Cancer

Location: C1M0

Presenting Author: – The University of Manchester

Co-Author: – University of Manchester

Co-Author: – Manchester Centre for Health Economics

Co-Author: – University of Manchester

Geriatric Pharmacoepidemiology

1:30 PM – 3:00 PM CEST

Moving from Trials to Real-World Evidence, Back and Forth

Location: Congress Hall D4

Moderator: – University of Utrecht

Moderator: – Canadian Agency for Drugs and Technologies in Health

Methods in Pharmacoepidemiology

1:30 PM – 1:45 PM CEST

Using Bias Correction Methods with Hybrid Randomized Controlled Trial (RCT) Plus Real World (RW) Controls to Replicate Results of a Phase Iib RCT of Baricitinib for Rheumatoid Arthritis (RA)

Location: Congress Hall D4

Presenting Author: – CorEvitas

Co-Author: – Eli Lilly and Company

Co-Author: – CorEvitas, LLC

Co-Author: – Eli Lilly and Company

Co-Author: – CorEvitas, LLC

Co-Author: – University of Pittsburgh Medical Center

Co-Author: – Eli Lilly and Company

Co-Author: – CorEvitas, LLC

Co-Author: – Eli Lilly and Company

Methods in Pharmacoepidemiology

1:45 PM – 2:00 PM CEST

Better Analysis of RCTs

Location: Congress Hall D4

Presenting Author: – UNC Gillings School of Global Public Health

Co-Author: – UNC Chapel Hill Gillings School of Global Public Health

Methods in Pharmacoepidemiology

2:00 PM – 2:15 PM CEST

Risk Ratios versus Hazard Ratios in Comparative Effectiveness Research: An Illustration Using Clinical Trial Data

Location: Congress Hall D4

Presenting Author: – UNC Gillings School of Global Public Health

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Co-Author: – University of North Carolina at Chapel Hill

Co-Author: – UNC Gillings School of Global Public Health

Methods in Pharmacoepidemiology

2:15 PM – 2:30 PM CEST

Differential Misclassification of Overdose Safety of in a Prominent Comparative Effectiveness RCT Comparing Buprenorphine and Naltrexone for Opioid Dependence

Location: Congress Hall D4

Presenting Author: – UNC Gillings School of Global Public Health

Co-Author: – The Wharton School, University of Pennsylvania

Co-Author: – University of North Carolina

Co-Author: – University of North Carolina at Chapel Hill

Methods in Pharmacoepidemiology

2:30 PM – 2:45 PM CEST

Predicting Treatment Effects of a New Drug in a Target Population Based on Randomized Controlled Trial Results

Location: Congress Hall D4

Presenting Author: – Harvard School of Public Health

Co-Author: – Harvard Medical School/Brigham & Women's Hospital

Co-Author: – Brigham and Women's Hospital

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Johnson & Johnson

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Brigham and Women's Hospital

Methods in Pharmacoepidemiology

2:45 PM – 3:00 PM CEST

How Choosing the Risk Ratio or the Risk Difference Changes Sufficient Adjustment Sets for External Validity

Location: Congress Hall D4

Presenting Author: – McGill University, Department of Epidemiology, Biostatistics, and Occupational Health

Co-Author: – University of North Carolina at Chapel Hill

Methods in Pharmacoepidemiology

1:30 PM – 3:00 PM CEST

Medicating for Two: Pregnancy, Maternal, and Infant Outcomes

Location: C1M2

Moderator: – Pfizer Inc

Moderator: – Radboud university medical center

Pregnancy and Lactation

1:30 PM – 1:45 PM CEST

Does Treating Genital Herpes Infection During Pregnancy Reduce the Risk of Preterm Delivery? A Prospective Cohort Study of 89,000 Pregnant Women

Location: C1M2

Presenting Author: – Kaiser Permanente

Co-Author: – Division of Research, Kaiser Foundation Research Institute

Co-Author: – The Permanente Medical Group

Co-Author: – Kaiser Permanente Northern California Division of Research

Drug Effectiveness

1:45 PM – 2:00 PM CEST

Prenatal Antibiotic Exposure and Subsequent Infections in Infancy: A Register-based Cohort Study in Sweden with Sibling Analysis

Location: C1M2

Presenting Author: – Karolinska Institutet

Co-Author: – Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet

Co-Author: – Department of Mental Disorders, Norwegian Institute of Public Health

Co-Author: – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet

Co-Author: – Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet

Co-Author: – Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet

Pregnancy and Lactation

2:00 PM – 2:15 PM CEST

Evaluating the Safety of Antiemetic Combination Use on Pregnancy Loss

Location: C1M2

Presenting Author: – University of Florida Department of Pharmaceutical Outcomes and Policy

Co-Author: – Center for Drug Evaluation and Safety, Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, FL USA

Co-Author: – Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL, USA

Co-Author: – Harvard Pilgrim Health Care Institute

Co-Author: – Departments of Pediatrics and Obstetrics and Gynecology, College of Medicine, University of Florida

Co-Author: – University of Florida

Pregnancy and Lactation

2:15 PM – 2:30 PM CEST

COVID-19 Vaccines During Pregnancy and Birth Defects; Preliminary Data from V-Safe COVID-19 Vaccine Pregnancy Registry, United States 2021

Location: C1M2

Presenting Author: – U.S. Centers for Disease Control and Prevention

Co-Author: – Centers for Disease Control and Prevention

Co-Author: – Goldbelt Professional Services

Co-Author: – Centers for Disease Control and Prevention

Pregnancy and Lactation

2:30 PM – 2:45 PM CEST

Initiation of Atenolol versus Methyldopa During Pregnancy and the Risk of Intrauterine Growth Restriction/small for Gestational Age

Location: C1M2

Presenting Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – Harvard Medical School

Co-Author: – Harvard School of Public Health

Co-Author: – Division of Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration

Co-Author: – Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Co-Author: – US Food and Drug Administration

Co-Author: – Pfizer, Inc. Worldwide Medical and Safety

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Co-Author: – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Pregnancy and Lactation

2:45 PM – 3:00 PM CEST

Characteristics and Medication Use Patterns of Pregnancies with COVID-19 in the Sentinel System

Location: C1M2

Presenting Author: – Harvard Medical School

Co-Author: – Harvard Pilgrim Health Care Institute

Co-Author: – Meyers Primary Care Institute

Co-Author: – Harvard Pilgrim Healthcare Institute

Co-Author: – Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute

Co-Author: – U.S. Food and Drug Administration

Co-Author: – US Food and Drug Administration

Co-Author: – Harvard Pilgrim Health Care Institute

Co-Author: – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration

Pregnancy and Lactation

3:00 PM – 3:30 PM CEST

Break/Exhibits/Posters

Location: Hall C

3:30 PM – 5:00 PM CEST

Considerations of Misclassification and Confounding on COVID-19 Vaccines Effectiveness Studies - A Vaccine SIG Endorsed Symposium

Location: Congress Hall D2

Presenting Author: – Optum Epidemiology

Author: – UNC Gillings School of Global Public Health

Author: – RTI Health Solutions

Author: – DHHS/FDA

Vaccines

3:30 PM – 5:00 PM CEST

Advanced Methods for Covariate Balancing: Going Beyond Propensity Score Matching and Weighting Using Optimization Techniques

Location: C1M0

Presenting Author: – Johnson & Johnson

Author: – Mu Sigma

Author: – University of Pennsylvania School of Medicine

Methods in Pharmacoepidemiology

3:30 PM – 5:00 PM CEST

Methods and Considerations for Hypothesis-free Signal Detection Studies Accommodating Various Types of Medications, Populations, and Regions

Location: C1M1

Presenting Author: – NCKU Institute of Clinical Pharmacy and Pharmaceutical Sciences

Author: – National Cheng Kung University

Author: – GSK

Author: – University of South Australia

Author: – Ewha Womans University

Author: – Harvard Pilgrim Health Care Institute

Author:

Author: – Harvard Pilgrim Health Care Institute

Pharmacovigilance

3:30 PM – 5:00 PM CEST

Meeting the Need for Research on Drug Safety During Lactation: An Overview of Approaches

Location: Congress Hall D5

Presenting Author: – HealthPartners Institute

Author: – University of California San Diego

Author: – University of California, San Diego

Author: – University of Oslo

Author: – Hospital for Sick Children / University of Toronto

Author: – UCB Biopharma

Author: – Center for Drug Evaluation and Research, Food and Drug Administration

Pregnancy and Lactation

3:30 PM – 5:00 PM CEST

It Takes a Village: Strategic Global Collaborations to Advance RWE Within ISPE

Location: C1M5

Presenting Author: – University of Utrecht

Author: – Harvard Medical School/Brigham & Women's Hospital

Author: – RTI Health Solutions

Author: – Reagan-Udall Foundation for the FDA

Author: – University of Utrecht

Author: – US Food and Drug Administration

Disease Epidemiology/Clinical Course

5:15 PM – 6:45 PM CEST

Methods - Comparators, Controls, and Unmeasured Confounding

Location: C1M5

Moderator: – Johnson & Johnson

Moderator: – Department of Clinical Epidemiology, Aarhus University

Methods in Pharmacoepidemiology

5:15 PM – 5:30 PM CEST

Using Active Comparators in Self-controlled Case Series: An Application to Two Studies in the Clinical Practice Research Datalink

Location: C1M5

Presenting Author: – London School of Hygiene and Tropical Medicine

Co-Author: – London School of Hygiene and Tropical Medicine

Co-Author: – GlaxoSmithKline R&D

Co-Author: – Epidemiology, Value Evidence & Outcomes, R&D, GlaxoSmithKline

Co-Author: – Department of Medical Statistics, London School of Hygiene and Tropical Medicine

Co-Author: – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT

Co-Author: – Research Statistics, GSK, Stevenage, UK

Methods in Pharmacoepidemiology

5:30 PM – 5:45 PM CEST

Negative Control Outcomes to Assess the Comparability of Biologics versus Small-molecule Therapeutics for Osteoporosis: Considerations for Differential Non-adherence

Location: C1M5

Presenting Author: – University of North Carolina at Chapel Hill

Co-Author: – Target RWE

Co-Author: – NoviSci

Co-Author: – Duke University

Methods in Pharmacoepidemiology

5:45 PM – 6:00 PM CEST

Evaluation of Methods for Unmeasured Confounding Control in Pharmacoepidemiology Using Healthcare Databases: An Empirical Study Concerning Drugs Inducing Prematurity

Location: C1M5

Presenting Author: – INSERM

Co-Author: – High-Dimensional Biostatistics for Drug Safety and Genomics, Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France

Methods in Pharmacoepidemiology

6:00 PM – 6:15 PM CEST

Alternative Analytic and Matching Approaches for the Prevalent New-user Design: A Simulation Study

Location: C1M5

Presenting Author: – McGill University, Department of Epidemiology, Biostatistics, and Occupational Health

Co-Author: – Janssen Scientific Affairs LLC

Co-Author: – Aetion, Inc

Co-Author: – UNC Gillings School of Global Public Health

Co-Author:

Co-Author: – Karolinska Institutet

Co-Author: – Patient Centered Outcomes Research Institute

Methods in Pharmacoepidemiology

6:15 PM – 6:30 PM CEST

Proton Pump Inhibitors and Myocardial Infarction: An Application of Active Comparators in a Self-controlled Case Series

Location: C1M5

Presenting Author: – London School of Hygiene and Tropical Medicine

Co-Author: – School of Nursing, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

Co-Author: – Department of Medicine, University of Hong Kong

Co-Author: – London School of Hygiene and Tropical Medicine

Co-Author: – Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT

Co-Author: – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China

Methods in Pharmacoepidemiology

6:30 PM – 6:45 PM CEST

Advantages of Splitting Switchers and New Users in the Prevalent New User Design

Location: C1M5

Presenting Author: – Karolinska Institutet

Co-Author: – McGill University, Department of Epidemiology, Biostatistics, and Occupational Health

Co-Author: – Janssen Scientific Affairs LLC

Co-Author: – UNC Gillings School of Global Public Health

Co-Author: – Aetion, Inc

Co-Author:

Co-Author: – Patient Centered Outcomes Research Institute

Methods in Pharmacoepidemiology

5:15 PM – 6:45 PM CEST

Pharmacoepidemiologic Methods and SARS-CoV-2

Location: Congress Hall D4

Moderator: – RTI Health Solutions

Moderator: – UPenn Center for Pharmacoepidemiology Research & Training

Methods in Pharmacoepidemiology

5:15 PM – 5:30 PM CEST

Influence of Incomplete Death Information on Cumulative Risk Estimates in United States Claims Data

Location: Congress Hall D4

Presenting Author: – Rollins School of Public Health, Emory University

Co-Author: – Department of Epidemiology, Emory University, Atlanta, GA

Co-Author: – Center for Observational Research, Amgen Inc., Thousand Oaks, CA

Co-Author: – Duke University

Co-Author: – Chronic Disease Research Group, Minneapolis, MN

Co-Author: – Center for Observational Research, Amgen Inc., Thousand Oaks, CA

Methods in Pharmacoepidemiology

5:30 PM – 5:45 PM CEST

Estimating Real-world Outcomes Under a Rapidly Evolving Treatment Paradigm: Dexamethasone and Inpatient Mortality Among US Hospitalized COVID-19 Patients

Location: Congress Hall D4

Presenting Author: – Aetion, Inc

Co-Author: – Aetion, Inc

Co-Author: – US Food and Drug Administration

Co-Author: – US Food and Drug Addministration

Co-Author: – US Food and Drug Administration

Co-Author: – Aetion, Inc

Co-Author: – HealthVerity

Co-Author: – Aetion, Inc.

Methods in Pharmacoepidemiology

5:45 PM – 6:00 PM CEST

Adjusting for Calendar Time in Analyses of COVID-19 Vaccine Safety and Effectiveness: A Simulation Study

Location: Congress Hall D4

Presenting Author:

Co-Author: – University of Southern Denmark

Co-Author: – Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark (SDU)

Methods in Pharmacoepidemiology

6:00 PM – 6:15 PM CEST

Evaluating the Comparative Effectiveness and Safety of Repurposed Drugs for COVID-19

Location: Congress Hall D4

Presenting Author: – Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences,University of Oxford

Co-Author: – National Institute for Health and Care Excellence, London, UK

Co-Author: – Observational Health Data Sciences and Informatics, New York, NY, USA

Co-Author: – Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford

Co-Author: – Janssen Pharmaceuticals, Inc.

Co-Author: – IDIAPJGol, Barcelona, Spain

Co-Author: – VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA

Co-Author: – Department of Biomedical Informatics, Columbia University, New York, NY, USA

Co-Author: – Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford

Co-Author: – VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT, USA

Co-Author: – VA Informatics and Computing Infrastructure, Tennessee Valley Healthcare System VA, Nashville, TN, USA

Co-Author: – IQVIA, Cambridge, MA, USA

Co-Author: – Erasmus University Medical Center, Rotterdam, The Netherlands

Co-Author: – Department of Biomedical Informatics, Columbia University, New York, NY, USA

Co-Author: – Observational Health Data Sciences and Informatics, New York, NY, USA

Co-Author: – CSM, NDORMS, University of Oxford

Co-Author: – Observational Health Data Sciences and Informatics, New York, NY, USA

Methods in Pharmacoepidemiology

6:15 PM – 6:30 PM CEST

Adjusting for Data Observation Delay in near Real-time Safety Surveillance of COVID-19 Vaccines Using Administrative Claims Databases

Location: Congress Hall D4

Presenting Author: – Acumen LLC

Co-Author: – Acumen, LLC

Co-Author: – Acumen LLc

Co-Author: – Acumen LLC

Co-Author: – Food and Drug Administration

Co-Author: – US Food and Drug Administration

Co-Author: – Acumen, LLC

Co-Author: – US Food and Drug Administration

Co-Author: – Optum

Co-Author: – HealthCore, Inc.

Co-Author: – IQVIA Government Solutions Inc.

Co-Author: – CVS Health

Co-Author: – DHHS/FDA

Co-Author: – Optum Epidemiology

Co-Author: – IQVIA, Cambridge, MA, USA

Co-Author: – CVS Health Clinical Trial Services

Co-Author: – Optum Epidemiology

Co-Author: – Food and Drug Administration

Co-Author: – US Food and Drug Administration

Methods in Pharmacoepidemiology

6:30 PM – 6:45 PM CEST

Near Real Time Safety Surveillance of COVID-19 Vaccines in the UK

Location: Congress Hall D4

Presenting Author: – Medicine and Healthcare products Regulatory Agency (UK)

Co-Author: – London School of Hygiene and Tropical Medicine

Co-Author: – UK Health Security Agency

Methods in Pharmacoepidemiology

5:15 PM – 6:45 PM CEST

Drug Utilization Studies in Cardiovascular Disease and Diabetes

Location: Congress Hall D5

Moderator: – Boehringer Ingelheim International GmbH

Moderator: – Pfizer Inc

Drug Utilization Research

5:15 PM – 5:30 PM CEST

UK Trends in Prescribing Preferences for Antidiabetic Medications Among Type 2 Diabetes Patients With and Without Chronic Kidney Disease, 2006-2020

Location: Congress Hall D5

Presenting Author:

Co-Author: – Drexel University College of Medicine

Co-Author: – Rutgers Robert Wood Johnson Medical School

Co-Author: – Rutgers Center for Pharmacoepidemiology and Treatment Science

Drug Utilization Research

5:30 PM – 5:45 PM CEST

Contemporary Trends in the Utilization of Second-line Pharmacological Therapies for Type 2 Diabetes in the United States

Location: Congress Hall D5

Presenting Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Massachusetts General Hospital

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Drug Utilization Research

5:45 PM – 6:00 PM CEST

Sex Disparities in Treatment Patterns After Metformin Initiation Among Patients with Type 2 Diabetes Mellitus

Location: Congress Hall D5

Presenting Author: – University Medical Center Groningen

Co-Author: – Research Institute of Pharmacy, Unit of PharmacoTherapy, -Epidemiology and Economics, University of Groningen, Groningen The Netherlands

Co-Author: – Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, Groningen, The Netherlands

Co-Author: – Unit of PharmacoTherapy, -Epidemiology, & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands

Co-Author: – University Medical Center Groningen

Drug Utilization Research

6:00 PM – 6:15 PM CEST

Continued Potassium Supplementation Use Following Loop Diuretic Discontinuation in Older Adults: An Evaluation of a "Prescribing Cascade Relic"

Location: Congress Hall D5

Presenting Author: – University of Florida Department of Pharmaceutical Outcomes and Policy

Co-Author: – 2. Department of Pharmacotherapy & Translational Research, University of Florida College of Pharmacy, Gainesville, Florida, United States

Co-Author: – University of Florida - Department of Pharmaceutical Outcomes & Policy

Co-Author: – University of Florida College of Pharmacy

Drug Utilization Research

6:15 PM – 6:30 PM CEST

Trends and Prescription Patterns of Medications for Secondary Stroke Prevention in Denmark, 2013—2018

Location: Congress Hall D5

Presenting Author:

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University & Aarhus University Hospital, Aarhus, Denmark

Co-Author: – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Mass General Hospital

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Drug Utilization Research

6:30 PM – 6:45 PM CEST

The Potential Impact of the Supplemental Nutrition Assistance Program (SNAP) on Adherence to Antihypertensive Medications

Location: Congress Hall D5

Presenting Author: – The Ohio State University

Drug Utilization Research

5:15 PM – 6:45 PM CEST

Pediatric Medicine Use: Safe Kids in an Uncertain Landscape

Location: C1M0

Moderator: – University of Hong Kong

Moderator: – PicnicHealth

Pediatric Pharmacoepidemiology

5:15 PM – 5:30 PM CEST

Trends in High-risk Prescribing to U.S. Pediatric Dental Patients, 2012-2019

Location: C1M0

Presenting Author: – University of Pittsburgh

Co-Author: – University of Pittsburgh School of Medicine

Co-Author: – Northwestern University

Co-Author: – Flatiron Health

Co-Author: – University of Pittsburgh School of Dental Medicine

Co-Author: – Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh

Co-Author: – University of Pittsburgh

Pediatric Pharmacoepidemiology

5:30 PM – 5:45 PM CEST

Identifying Acute Neuropsychiatric Events in Children and Adolescents

Location: C1M0

Presenting Author: – Vanderbilt University School of Medicine

Co-Author: – University of Colorado

Co-Author: – Vanderbilt University Medical Center

Co-Author: – Colorado Children's Hospital

Co-Author: – Vanderbilt University Medical Center

Pediatric Pharmacoepidemiology

5:45 PM – 6:00 PM CEST

Comprehensive Assessment of Paediatric SARS-CoV-2 Infection: A Danish Population-based Cohort Study

Location: C1M0

Presenting Author: – Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark (SDU)

Co-Author:

Co-Author: – University of Southern Denmark

Co-Author: – Department of Pediatrics and Adolescent Medicine,The Juliane Marie Centre, Rigshospitalet

Co-Author: – University of Southern Denmark

Pediatric Pharmacoepidemiology

6:00 PM – 6:15 PM CEST

Inappropriate Antibiotic Prescriptions and the Risk of Adverse Drug Events Among Children Treated for Common Infections

Location: C1M0

Presenting Author: – Washington University School of Medicine

Co-Author: – Washington University School of Medicine

Co-Author: – Pew Charitable Trusts

Co-Author: – Washington University School of Medicine

Drug Utilization Research

6:30 PM – 6:45 PM CEST

Comparative Safety of Tozinameran in Children versus Adolescents: An Analysis of First Pharmacovigilance Data

Location: C1M0

Presenting Author: – CHU Toulouse - Service de pharmacologie

Co-Author: – Pediatric cardiology unit, Children Hospital, CHU Toulouse, 330 Avenue de Grande Bretagne TSA 70034, 31059, Toulouse cedex 9, France, Institut Des Maladies Métaboliques Et Cardiovasculaires, Université de Toulouse, INSERM U1048, I2MC, France

Co-Author: – Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital, Faculty of Medicine, Toulouse, France

Co-Author: – Departement of Pharmacology, Centre of Pharmacovigilance, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France

Co-Author: – The Pediatric Emergency Department, Children's Hospital, Toulouse University Hospital (CHU), France

Pediatric Pharmacoepidemiology

5:15 PM – 6:45 PM CEST

Smörgåsbord

Location: C1M1

Moderator: – McGill University

Moderator: – Genesis Research, LLC

Potpourri

5:15 PM – 5:30 PM CEST

Association Between Children Prescription Drug Costs for New Medications and Their Parent's Adherence to Chronic Medication

Location: C1M1

Presenting Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Health Economics/Outcomes Research

5:30 PM – 5:45 PM CEST

The Impact of Using Pictorial Aids in Caregivers' Understanding of Patient Information Leaflets of Pediatric Pain Medications: A Quasi-experimental Study

Location: C1M1

Presenting Author: – Saudi Food and Drug Authority (Saudi FDA)

Co-Author: – KSU

Co-Author:

Co-Author: – KSUMC

Co-Author: – KSU

Co-Author: – SAudi FDA

Benefit-Risk Assessment, Communication, and Evaluation (BRACE)

5:45 PM – 6:00 PM CEST

Does Left Atrial Dilation Predict Atrial Fibrillation Severity and Post-ablation Outcomes Among Individuals with Atrial Fibrillation?

Location: C1M1

Presenting Author: – University of Pennsylvania School of Medicine

Co-Author: – Mercy Clinic, St. Louis, Missouri, USA

Co-Author: – Johnson & Johnson

Medical Devices

6:00 PM – 6:15 PM CEST

Patient Groups in Rheumatoid Arthritis Identified by Deep Learning Respond Differently to Biologic or Targeted Synthetic Disease Modifying Antirheumatic Drugs

Location: C1M1

Presenting Author: – ETH Zurich

Co-Author: – University of Freiburg

Co-Author: – Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences

Co-Author: – University Hospital Lausanne (CHUV)

Biologics/Biosimilars

6:15 PM – 6:30 PM CEST

Anticoagulant Therapy and Risk of Kidney Disease - A Nationwide Cohort Study

Location: C1M1

Presenting Author: – Department of Clinical Epidemiology, Aarhus University

Co-Author: – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark

Co-Author: – Department of Clinical Epidemiology, Aarhus University

Co-Author: – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University & Aarhus University Hospital, Aarhus, Denmark

Co-Author: – Department of Clinical Medicine, Aarhus University, Denmark

Co-Author:

Benefit-Risk Assessment, Communication, and Evaluation (BRACE)

6:30 PM – 6:45 PM CEST

Costs Associated with Healthcare Resources Utilization Among Empagliflozin vs GLP-1RA Initiators in Routine Clinical Care in Denmark

Location: C1M1

Presenting Author: – Aarhus University

Co-Author: – Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University

Co-Author: – Boehringer Ingelheim International GmbH, Ingelheim

Co-Author: – Boehringer Ingelheim A/S, Copenhagen

Co-Author: – Nordic Institute of Health Economics (NIHE)

Co-Author: – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark

Health Economics/Outcomes Research

5:15 PM – 6:45 PM CEST

Lightning Session 1

Location: C1M2

Moderator: – Johns Hopkins University

Moderator: – University of Technology Sydney

Moderator: – University of Pennsylvania

Lightning Session 1

5:15 PM – 5:20 PM CEST

Risk of Myasthenia Gravis with Tyrosine Kinase Inhibitors: A Disproportionality Analysis from Vigibase and AERS Databases

Location: C1M2

Presenting Author: – University of Basel

Co-Author: – Safety Signal Detection & MQM, Novartis

Co-Author: – Clinical Development Oncology, Novartis, Basel, Switzerland

Co-Author: – Patient Safety Oncology, Novartis, Basel, Switzerland

Co-Author: – Patient Safety Oncology, Novartis, New Jersey, USA

Co-Author: – Patient Safety Oncology, Novartis, Basel, Switzerland

Co-Author: – Safety Signal Detection & MQM, Novartis

Cancer

5:20 PM – 5:25 PM CEST

Breast Cancer and Subsequent Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

Location: C1M2

Presenting Author: – Aarhus University

Co-Author: – Department of clinical epidemiology, Aarhus University & Aarhus University Hospital

Co-Author: – Aarhus University

Co-Author: – Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

Co-Author: – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark

Cancer

5:25 PM – 5:30 PM CEST

Risk of Pancreatitis and Pancreatic Carcinoma for Anti-diabetic Medications: Evidence Synthesis from Disproportionality Analysis

Location: C1M2

Presenting Author: – NIPER Guwahati

Co-Author: – National Institute of Pharmaceutical Education and Research (NIPER), Guwahati

Co-Author: – National Institute of Pharmaceutical Education and Research,Guwahati

Cancer

5:30 PM – 5:35 PM CEST

Cardiovascular Risk Among Adolescents and Young Adults Initiating Cardiotoxic Cancer Chemotherapy and Concurrent QTc Interval-prolonging Antidepressants

Location: C1M2

Presenting Author: – University of Maryland School of Pharmacy

Co-Author: – Pharmaceutical Health Services Research, School of Pharmacy

Co-Author: – Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore MD, USA

Co-Author: – University of Maryland

Cancer

5:45 PM – 5:50 PM CEST

Longer-term Effectiveness of Home Blood Pressure Self-monitoring Plus Self-titration of Antihypertensive Medication for Poorly Controlled Hypertension in Primary Care: An Extension of the ADAMPA Trial

Location: C1M2

Presenting Author: – Foundation for the Promotion of Health and Biomedical Research of Valencia Region

Co-Author: – FISABIO

Co-Author: – INCLIVA

Co-Author: – Foundation for the Promotion of Health and Biomedical Research of the Valencia Region, Spain

Co-Author: – FISABIO

Drug Utilization Research

5:50 PM – 5:55 PM CEST

The Impact of COVID-19 Pandemic on Drug Utilization Patterns: A Population-based Cohort Study in Manitoba, Canada

Location: C1M2

Presenting Author: – The University of Manitoba

Co-Author: – The University of Manitoba

Co-Author: – College of Pharmacy, University of Manitoba

Co-Author: – College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba

Co-Author: – College of Pharmacy, Rady Faculty of Health Sciences University of Manitoba, Winnipeg, Canada.

Co-Author: – University of Manitoba

Co-Author: – The University of Manitoba

Drug Utilization Research

5:55 PM – 6:00 PM CEST

Morbidity Consequences of Misuse of Psychoactive Prescription Drugs in Portugal: The MisuMedPT Project

Location: C1M2

Presenting Author: – INFARMED - National Authority of Medicines and Health Products, I.P.

Co-Author: – iMed.ULisboa – Research Institute for Medicines, Faculty of Pharmacy, University of Lisbon

Co-Author: – SICAD - General-Directorate for Intervention on Addictive Behaviours and Dependencies

Co-Author: – iMed.ULisboa – Research Institute for Medicines, Faculty of Pharmacy, University of Lisbon

Drug Utilization Research

6:00 PM – 6:05 PM CEST

Global Trends in Antidepressant, Atypical Antipsychotic, and Benzodiazepine Use: A Cross-sectional Analysis of 64 Countries

Location: C1M2

Presenting Author: – University of Pittsburgh

Co-Author: – University of Pittsburgh

Co-Author: – University of Toronto

Co-Author:

Drug Utilization Research

6:15 PM – 6:20 PM CEST

Effectiveness and Safety of Empagliflozin in Routine Care: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

Location: C1M2

Presenting Author: – Brigham and Women's Hospital/Harvard Medical School

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Co-Author: – Brigham and Women's Hospital, Harvard Medical School

Co-Author: – Massachusetts General Hospital

Co-Author: – Brigham and Women's Hospital

Co-Author: – Harvard Medical School, Brigham and Women's Hospital

Co-Author: – Boehringer Ingelheim International GmbH

Co-Author: – Brigham and Women's Hospital

Co-Author: – Lilly Deutschland

Co-Author: – BWH Div of Pharmacoepidemiology and Pharmacoeconomics

Co-Author: – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Diabetes

6:20 PM – 6:25 PM CEST

Association Between Glycemic Control and Risk of Venous Thromboembolism in Diabetic Patients: A Nested Case—control Study

Location: C1M2

Presenting Author: – University of Basel

Co-Author: – Division of Endocrinology, Diabetes & Metabolism, University Hospital Basel, Basel, Switzerland

Co-Author: – Boston Collaborative Drug Surveillance Program

Co-Author: – Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland

Co-Author: – University of Basel

Diabetes

6:25 PM – 6:30 PM CEST

Diabetes Severity and the Risks of COVID-19 Infection and Severe COVID-19 Outcomes

Location: C1M2

Presenting Author: – Kaiser Permanente Washington Health Research Institute

Co-Author: – Department of Medicine, University of Washington

Co-Author: – Kaiser Permanente Washington Health Research Institute

Co-Author: – Kaiser Permanente Center for Health Research

Co-Author: – Kaiser Permanente Washington Health Research Institute

Co-Author: – Kaiser Permanente Center for Health Research

Co-Author: – Institute for Health Research, Kaiser Permanente Colorado

Co-Author: – Kaiser Permanente Washington Health Research Institute

Co-Author: – Institute for Health Research, Kaiser Permanente Colorado

Co-Author: – Kaiser Permanente Center for Health Research

Co-Author: – Kaiser Permanente Washington Health Research Institute

Diabetes

6:30 PM – 6:35 PM CEST

Liraglutide and Unexpected Psychiatric Adverse Events in Patients with Obesity: A Pharmacovigilance Study with Machine Learning Approach

Location: C1M2

Presenting Author: – School of Pharmacy, Sungkyunkwan University

Co-Author: – Sungkyunkwan University

Co-Author: – School of Pharmacy, Sungkyunkwan University

Diabetes

7:00 PM – 8:00 PM CEST

SIG Meetings

8:00 PM – 10:00 PM CEST

PDS Editorial Board

Location: Bella Sky Room 181

8:30 PM – 11:00 PM CEST

Students/Early Career Professionals Meet & Greet